Endocrine mechanisms in the sarcopenia model following distal radius fracture

Endocrine mechanisms in the sarcopenia model following distal radius fracture - EndoSarkRad

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039315

Enrollment

Registered

2026-05-26

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M62.50

Interventions

Group 1: Diagnosis of a distal radius fracture with indication for conservative treatment. All patients > 50 years of age are included in the study, both genders are considered.

Eligibility

Sex/Gender

All

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of a distal radius fracture with indication for conservative treatment. All patients > 50 years of age are included in the study, both genders are considered.

Exclusion criteria

Exclusion criteria: Contraindications for performing an MRI.

Design outcomes

Primary

Measure	Time frame
Muscle fat and muscle atrophy are to be assessed in MRI scans as primary radiological endpoints. The somatotropic, gonadotropic, and corticotropic axes are to be evaluated as primary endocrinological endpoints.	—

Secondary

Measure	Time frame
Sarcopenia, osteoporosis, and obesity are to be quantified as secondary clinical endpoints.	—

Countries

Germany

Contacts

Public ContactNina Hesse

LMU Klinikum

Nina.Hesse@med.uni-muenchen.de+49 89 4400 31321

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026